# Concentrations of Voriconazole in Blood and BAL-fluid After Inhalation and Oral Administration

> **NCT02396225** · NA · TERMINATED · sponsor: **University of Aarhus** · enrollment: 12 (actual)

## Conditions studied

- Invasive Aspergillosis

## Interventions

- **DRUG:** Voriconazole

## Key facts

- **NCT ID:** NCT02396225
- **Lead sponsor:** University of Aarhus
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-03
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** results obtained at interrim analysis after 12 patients would not be changed by recruiting another twelwe participants
- **Last updated:** 2017-05-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02396225

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02396225, "Concentrations of Voriconazole in Blood and BAL-fluid After Inhalation and Oral Administration". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02396225. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*